Global Biologics Market, By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Treatment (Vaccines, Recombinant Proteins, Blood Components and Others), Route of Administration (Injection, Infusion), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027
Biologics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. The rising prevalence of chronic and acute diseases anticipated the factor responsible for driving the growth of the biologics market.
A biologic drug is a product that is produced from living organism and contain component of living organism. Biologics contain recombinant protein, tissues, allergan, genes, cells, blood components, blood and vaccines. Biologics are used to treat numerous disease conditions and infections such as anaemia, haemophilia, chronic migraine, hepatitis B, rheumatoid arthritis, inflammatory bowel diseases and others.
Due to ability to command high prices for biologics considering the small molecules used for treatment of chronic diseases, various government initiatives, increased share of biologics in the market, increased rising adoption of biopharmaceuticals over chemically synthesized molecules and many more are the factors which boost up the growth of the biologics market in the above mentioned period. However, the developments of biosimilar, the unframed regulatory approval pathway, pricing pressures from regulators, technological advancements in healthcare access are the factors restraining the growth of the biologics market. Furthermore, demand for biologics in the treatment of complex diseases, increasing demand for next-generation biologics and rising R&D activities in the field of biopharmaceutical activities provides an opportunistic growth in the development of the biologics market.
This biologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Biologics Market Scope and Market Size
The biologics market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of type, the biologics market is segmented into monoclonal antibodies, therapeutic proteins and vaccines.
- On the basis of treatment, the biologics market is segmented into vaccines, recombinant proteins, blood components and others.
- On the basis of route of administration, the biologics market is segmented into injection and infusion.
- On the basis of end-users, the biologics market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the biologics market has also been segmented into hospital pharmacy, retail pharmacy and others.
Global Biologics Market Country Level Analysis
Global biologics is analysed and market size information is provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the biologics market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to owing strategic collaborations and partnerships for the development of biologics treatment for acute and various chronic diseases. Asia-Pacific is expected to account for the largest market share over coming years for the biologics market due to increased prevalence of rheumatoid arthritis, kidney and liver diseases and rising number of geriatric population.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global biologics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to biologics market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the biologics market in the growth period.
Competitive Landscape and Biologics Market Share Analysis
Global biologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to biologics market.
The major players covered in the biologics market are Bristol-Myers Squibb Company (BMS), Merck & Co., Inc., Roche AG, AstraZeneca Plc, Regeneron Pharmaceuticals, Inc, Novartis International AG, Pfizer, Inc., Amgen, Inc., AbbVie, Inc., Sanofi S.A., Eli Lilly & Company, Novo Nordisk A/S, Johnson & Johnson Services Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen S.A., Allergan Plc among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Biologics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.